Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris

Platelets

Volumn 17, Issue 8, 2006, Pages 565-570

  Inami, Norihito ^a   Nomura, Shosaku ^b   Manabe, Kenichi ^a   Kimura, Yutaka ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Kishiwada City Hospital   (Japan)

Author keywords

Percutaneous coronary intervention; Regulated on activation normally T cell expressed and secreted; Restenosis; Soluble L selectin

Indexed keywords

CHEMOKINE; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RANTES;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD PROTEINS; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; RANTES; TIME FACTORS;

ANGINA;

EID: 33751540950     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100600759618     Document Type: Article

References (21)

1. Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, et al. ACC/AHA Guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - executive summary. Circulation 2001;103:3019-3041.
2. Califf RN, Fortin DF, Frid DJ, Harlan WR 3rd, Ohman EM, Bengtson JR, Nelson CL, Tcheng JE, Mark DB, Stack RS. Restenosis after coronary angioplasty: An overview. J Am Coll Cardiol 1991;17:2-13B.
3. Fitzgerald DJ, Roy I, Catella F, FitzGerald GA. Platelet activation in unstable angina. New Engl J Med 1986;315:983-989.
4. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001;21:327-334.
5. Schwager I, Jungi TW. Effect of recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994;83:152-161.
6. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997;17:3399-3405.
7. Baggiolini M, Deward B, Moster B. Interleukin-8 and related chemotactic cytokines -CXC and CC chemokines. Adv Immunol 1994;55:97-179.
8. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992;176:587-592.
9. Holme PA, Muller F, Solum NO, Brosstad F, Froland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in HIV-1 infection. FASEB J 1998;12:79-89.
10. Matsumoto N, Nomura S, Kamihata H, Kimura Y, Iwasaka T. Association of platelet-derived microparticles with C-C chemokines on vascular complication in patients with acute myocardial infarction. Clin Appl Thromb Hemost 2002;8:279-286.
11. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 2003;89:506-512.
12. Ross R. Atherosclerosis - An inflammatory disease. New Engl J Med 1999;340:115-126.
13. Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
14. Inoue T, Sakai Y, Fujito T, Hoshi K, Hayashi T, Takayanagi K, Morooka S. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis. Thromb Haemost 1998;79:54-58.
15. Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus ballon angioplasty for stable angina pectoris. Am J Cardiol 2000;86:1057-1062.
16. Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003;107:1757-1763.
17. Welt FGP, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002;22:1769-1776.
18. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, Gioffre PA. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998;82:515-518.
19. Bahrmann P, Sigusch HH, Surber R, Figulla HR. Oral antiplatelet therapies have no effect on circulating levels of RANTES in patients with coronary artery disease. Pharmazie 2002;57:863-864.
20. Welt FG, Rogers SD, Zhang X, Ehlers R, Chen Z, Nannizzi-Alaimo L, Phillips DR, Simon DI. GPIIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheter Cardiovasc Interv 2004;61:185-189.
21. Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, Sarembock IJ, Ley K, Weber C. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002;106:1523-1532.